デフォルト表紙
市場調査レポート
商品コード
1067872

オランザピンの世界市場-業界分析、市場規模、シェア、成長、動向、予測(2022年~2028年)

Global Olanzapine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

出版日: | 発行: Value Market Research | ページ情報: 英文 306 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
オランザピンの世界市場-業界分析、市場規模、シェア、成長、動向、予測(2022年~2028年)
出版日: 2022年03月01日
発行: Value Market Research
ページ情報: 英文 306 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の当レポートでは、世界のオランザピン市場について調査分析し、業界分析、市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 オランザピン-業界分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
  • 潜在的な買い手のリスト
  • マーケティングチャネル

第5章 COVID-19アウトブレイクの影響分析

  • COVID-19アウトブレイクの影響分析
  • COVID-19影響分析:生産、輸入、輸出および需要別
  • 市場:COVID-19以前 vs COVID-19以後
  • コロナウイルス(COVID-19)の流行の推定影響
  • COVID-19:ミクロおよびマクロ因子分析

第6章 世界のオランザピン市場分析:治療タイプ別

  • 概要:治療タイプ別
  • 実績データと予測データ
  • 分析:治療タイプ別
  • 単剤療法の販売実績および予測:地域別
  • 併用療法の販売実績および予測:地域別

第7章 世界のオランザピン市場分析:アプリケーション別

  • 概要:アプリケーション別
  • 実績データと予測データ
  • 分析:アプリケーション別
  • 統合失調症の販売実績および予測:地域別
  • 双極性障害の販売実績および予測:地域別
  • その他の販売実績および予測:地域別

第8章 世界のオランザピン市場分析:流通チャネル別

  • 概要:流通チャネル別
  • 実績データと予測データ
  • 分析:流通チャネル別
  • 病院薬局の販売実績および予測:地域別
  • オンライン薬局の販売実績および予測:地域別
  • 小売薬局の販売実績および予測:地域別

第9章 世界のオランザピン市場分析:エンドユーザー別

  • 概要:エンドユーザー別
  • 実績データと予測データ
  • 分析:エンドユーザー別
  • 病院の販売実績および予測:地域別
  • 在宅医療の販売実績および予測:地域別
  • 専門クリニックの販売実績および予測:地域別
  • その他の販売実績および予測:地域別

第10章 世界のオランザピン市場分析:地域別

  • 地域の展望
  • イントロダクション
  • 北米の販売分析
  • 欧州の販売分析
  • アジア太平洋の販売分析
  • ラテンアメリカの販売分析
  • 中東・アフリカの販売分析

第11章 オランザピン企業の競合情勢

  • オランザピン市場における競争
  • パートナーシップ/コラボレーション/契約
  • 合併と買収
  • 新製品の発売
  • その他の開発

第12章 企業プロファイル

  • 主要企業の市場シェア分析
  • 市場集中度
  • WATSON Pharmaceuticals
  • Changzhou Huasheng Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  • Sandoz International GmbH
  • Zhejiang Langhua Pharmaceutical Co., Ltd.
  • Aurobindo Pharma
  • Jubilant Pharmova Limited
  • Torrent Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Dr. Reddy's Laboratories
  • Mylan NV
  • Apotex Inc.
  • Teva Pharmaceutical Industries Ltd.

注:企業プロファイリングにおける財務の詳細と最近の開発に関しては、情報公開次第となります。民間企業の場合はカバーされない場合があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Therapy Type (USD MN)
  • Monotherapy Therapy Market Sales by Geography (USD MN)
  • Combinational Therapy Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Schizophrenia Market Sales by Geography (USD MN)
  • Bipolar Disorder Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Online Pharmacy Market Sales by Geography (USD MN)
  • Retail Pharmacy Market Sales by Geography (USD MN)
  • Analysis by End-Users (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Olanzapine Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Olanzapine Report
  • Market Research Process
  • Market Research Methodology
  • Global Olanzapine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapy Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by End-Users
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis Therapy Type (USD MN)
  • Monotherapy Therapy Market Sales by Geography (USD MN)
  • Combinational Therapy Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Schizophrenia Market Sales by Geography (USD MN)
  • Bipolar Disorder Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Online Pharmacy Market Sales by Geography (USD MN)
  • Retail Pharmacy Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Users (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top 10 Company Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11217681

Value Market Research deeply researched the Global Olanzapine Market to foresee a significant growth in the industry over the upcoming years. The global olanzapine market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global olanzapine market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this olanzapine market.

The next sections of the olanzapine market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Therapy Type

Monotherapy Therapy

Combinational Therapy

By Application

Schizophrenia

Bipolar Disorder

Other

By Distribution Channel

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

By End-Users

Hospitals

Homecare

Specialty Clinics

Others

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . OLANZAPINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By End-Users
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL OLANZAPINE MARKET ANALYSIS BY THERAPY TYPE

  • 6.1 Overview by Therapy Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapy Type
  • 6.4 Monotherapy Therapy Historic and Forecast Sales by Regions
  • 6.5 Combinational Therapy Historic and Forecast Sales by Regions

7 . GLOBAL OLANZAPINE MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Schizophrenia Historic and Forecast Sales by Regions
  • 7.5 Bipolar Disorder Historic and Forecast Sales by Regions
  • 7.6 Other Historic and Forecast Sales by Regions

8 . GLOBAL OLANZAPINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacy Historic and Forecast Sales by Regions
  • 8.5 Online Pharmacy Historic and Forecast Sales by Regions
  • 8.6 Retail Pharmacy Historic and Forecast Sales by Regions

9 . GLOBAL OLANZAPINE MARKET ANALYSIS BY END-USERS

  • 9.1 Overview by End-Users
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End-Users
  • 9.4 Hospitals Historic and Forecast Sales by Regions
  • 9.5 Homecare Historic and Forecast Sales by Regions
  • 9.6 Specialty Clinics Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL OLANZAPINE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE OLANZAPINE COMPANIES

  • 11.1. Olanzapine Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF OLANZAPINE INDUSTRY

  • 12.1. Top 10 Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. WATSON Pharmaceuticals
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Changzhou Huasheng Pharmaceutical Co., Ltd.
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Sandoz International GmbH
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Zhejiang Langhua Pharmaceutical Co., Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Aurobindo Pharma
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Jubilant Pharmova Limited
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Torrent Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Sun Pharmaceutical Industries Ltd.
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Eli Lilly and Company
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Dr. Reddy's Laboratories
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Mylan N.V.
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Apotex Inc.
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Teva Pharmaceutical Industries Ltd.
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies